Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Urinary Bladder Neoplasms × Selenium × Clear all

Phase

Status

Unknown 2 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 10 Precancerous Conditions 3 Male Urogenital Diseases 2 Colonic Neoplasms 2 Urinary Bladder Neoplasms 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Rectal Neoplasms 1 Non-melanoma Skin Cancer 1 Neoplasms 1 Lung Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Arsenic Poisoning 1 Adenomatous Polyps 1

Interventions

Gemcitabine 66 Cisplatin 47 pembrolizumab 29 Paclitaxel 25 Carboplatin 22 Docetaxel 16 Radiotherapy 15 atezolizumab 14 Doxorubicin 14 Mitomycin 12 BCG Vaccine 12 vinflunine 10 Nivolumab 10 Methotrexate 10 Filgrastim 10 Cystectomy 10 Vinblastine 9 Fluorouracil 9 5-aminolevulinic acid hexyl ester 9 Early Intervention, Educational 7 durvalumab 6 Sunitinib 6 Methods 6 Cystoscopy 6 enfortumab vedotin 5 avelumab 5 Trastuzumab 5 Taxes 5 Standard of Care 5 Ifosfamide 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00729287 2016-05-12

SELEBLAT

KU Leuven

Phase 3 Completed

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡